Starpharma Holdings Ltd has released a press release.
Adama Licenses Starpharmas Priostar for Novel 2,4-D
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Starpharma licences VivaGel BV to Aspen for ANZ
- Targeted DEP shows sustained superior performance
- VivaGel phase 3 study results
- VivaGel Demonstrates Efficacy in Bacterial Vaginosis
- VivaGel condom patent grant extends coverage
Later from Starpharma
- DEP docetaxel - longer duration and increased exposure
- SPL: VivaGel condom approved for sale with launch imminent
- SPP Record Date Clarification
- Starpharma receives $4.2M R&D tax incentive refund
- FDA Grants SPA Agreement for Phase 3 Recurrent BV Trial
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma